XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 262,763 $ 117,231
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation, depletion and amortization 92,258 82,128
Deferred income tax expense 88,002 64,287
Loss on sale of assets 1,500 41,049
Exploratory dry hole cost 13 (60)
Gain on derivative instruments (8,257) (5,577)
Net cash received (paid) in settlement of derivative instruments 52,980 (26,131)
(Earnings) loss on equity method investments (3,684) 994
Distribution of earnings from equity method investments 4,729 0
Amortization of debt issuance costs 1,089 1,195
Stock-based compensation and other 14,474 5,184
Changes in assets and liabilities:    
Accounts receivable, net 141,671 50,216
Income taxes 6,786 (24,646)
Inventories (7,201) (4,309)
Other current assets 1,119 1,023
Accounts payable and accrued liabilities (27,934) (14,169)
Interest payable (12,887) (15,318)
Other assets and liabilities (22,134) (337)
Net cash provided by operating activities 585,287 272,760
CASH FLOWS FROM INVESTING ACTIVITIES    
Capital expenditures (195,650) (156,257)
Proceeds from sale of assets 2,346 646,545
Investment in equity method investments (1,828) (35,418)
Net cash provided by (used in) investing activities (195,132) 454,870
CASH FLOWS FROM FINANCING ACTIVITIES    
Borrowings from debt 95,000 0
Repayments of debt (102,000) 0
Treasury stock repurchases (31,378) (207,134)
Dividends paid (29,605) (27,647)
Tax withholdings on vesting of stock awards (9,570) (7,968)
Net cash used in financing activities (77,553) (242,749)
Net increase in cash and cash equivalents 312,602 484,881
Cash and cash equivalents, beginning of period 2,287 480,047
Cash and cash equivalents, end of period $ 314,889 $ 964,928